Home | Publications | Generic Drugs place holder
place holder place holder

Generic Drugs

Generics

Global Industry Guide

Publication Date   October 2007
Publisher   Datamonitor
Product Type   Strategic Report
Pages   195
ISBN Number   not applicable
Product Code   DAT1018
Ask a question about this product?

Price £525.00

approximately: $1,040 | €667

Summary


Datamonitor's Generics: Global Industry Guide is an essential resource for top-level data and analysis covering the generics industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis.

Scope of the Report

  • Contains an executive summary and data on value, volume and segmentation
  • Provides textual analysis of the industry's prospects, competitive landscape and profiles of the leading companies
  • Covers the Global, European and Asia-Pacific markets as well as individual chapters on 5 major markets (France, Germany, Japan, the UK and the US).
  • Includes a five-year forecast of the industry

Highlights

The global generics market grew by 14.2% in 2006 to reach a value of $92.7 billion.

In 2011, the market is forecast to have a value of $155.7 billion, an increase of 68% since 2006.

The ethical generic segment generates 76.8% of the global market's aggregate value.

Americas accounts for 41.9% of the global market's total value

Why you should buy this report

  • Spot future trends and developments
  • Inform your business decisions
  • Add weight to presentations and marketing materials
  • Save time carrying out entry-level research

Market Definition

The value of the generics market consists of all sales of generics drugs at ex-manufacturers prices. The market does not include animal healthcare products. Datamonitor defines a generic as a product, which is an officially approved copy of an original product whose patent has expired, marketed either as a brand or using the generic name. This definition excludes multi-source copy products that make up much of markets such as India, Spain and Italy. All currency conversions have been calculated at constant 2006 average exchange rates.

For the purpose of this report the Americas comprises Brazil, Canada, Mexico and the US.

Europe comprises Belgium, the Czech Republic, Denmark, France, Germany, Hungary, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden and the UK.

Asia-Pacific comprises Australia, China, Japan, India, Singapore, South Korea and Taiwan.

The global figure comprises the Americas, Asia-Pacific and Europe.

Content


  • Chapter 1 Introduction
    • 1.1 What is this report about?
    • 1.2 Who is the target reader?
    • 1.3 How to use this report
    • 1.4 Definitions
  • Chapter 2 Global Generics
    • 2.1 Market Overview
    • 2.2 Market Value
    • 2.3 Market Segmentation I
    • 2.4 Market Segmentation II
    • 2.5 Five Forces Analysis
    • 2.6 Market Forecasts
  • Chapter 3 Generics in Asia-Pacific
    • 3.1 Market Overview
    • 3.2 Market Value
    • 3.3 Market Segmentation I
    • 3.4 Market Segmentation II
    • 3.5 Five Forces Analysis
    • 3.6 Market Forecasts
  • Chapter 4 Generics in Europe
    • 4.1 Market Overview
    • 4.2 Market Value
    • 4.3 Market Segmentation I
    • 4.4 Market Segmentation II
    • 4.5 Five Forces Analysis
    • 4.6 Market Forecasts
    • 4.7 Macroeconomic Indicators
  • Chapter 5 Generics in Belgium
    • 5.1 Market Overview
    • 5.2 Market Value
    • 5.3 Market Segmentation I
    • 5.4 Market Segmentation II
    • 5.5 Five Forces Analysis
    • 5.6 Market Forecasts
    • 5.7 Macroeconomic Indicators
  • Chapter 6 Generics in Canada
    • 6.1 Market Overview
    • 6.2 Market Value
    • 6.3 Market Segmentation I
    • 6.4 Market Segmentation II
    • 6.5 Five Forces Analysis
    • 6.6 Market Forecasts
    • 6.7 Macroeconomic Indicators
  • Chapter 7 Generics in China
    • 7.1 Market Overview
    • 7.2 Market Value
    • 7.3 Market Segmentation I
    • 7.4 Market Segmentation II
    • 7.5 Five Forces Analysis
    • 7.6 Market Forecasts
    • 7.7 Macroeconomic Indicators
  • Chapter 8 Generics in France
    • 8.1 Market Overview
    • 8.2 Market Value
    • 8.3 Market Segmentation I
    • 8.4 Market Segmentation II
    • 8.5 Five Forces Analysis
    • 8.6 Forecasts
    • 8.7 Macroeconomic Indicators
  • Chapter 9 Generics in Germany
    • 9.1 Market Overview
    • 9.2 Market Value
    • 9.3 ket Segmentation I
    • 9.4 Market Segmentation II
    • 9.5 Five Forces analysis
    • 9.6 Market Forecasts
    • 9.7 Macroeconomic Indicators
  • Chapter 10 Generics in Italy
    • 10.1 Market Overview
    • 10.2 Market Value
    • 10.3 Market Segmentation I
    • 10.4 Market Segmentation II
    • 10.5 Five Forces Analysis
    • 10.6 Market Forecasts
    • 10.7 Macroeconomic Indicators
  • Chapter 11 Generics in Japan
    • 11.1 Market Overview
    • 11.2 Market Value
    • 11.3 Market Segmentation I
    • 11.4 Market Segmentation II
    • 11.5 Five Forces Analysis
    • 11.6 Market Forecasts
    • 11.7 Macroeconomic Indicators
  • Chapter 12 Generics in The Netherlands
    • 12.1 Market Overview
    • 12.2 Market Value
    • 12.3 Market Segmentation I
    • 12.4 Market Segmentation II
    • 12.5 Five Forces Analysis
    • 12.6 Market Forecasts
    • 12.7 Macroeconomic Indicators
  • Chapter 13 Generics in Spain
    • 13.1 Market Overview
    • 13.2 Market Value
    • 13.3 Market Segmentation I
    • 13.4 Market Segmentation II
    • 13.5 Five Forces Analysis
    • 13.6 Market Forecasts
    • 13.7 Macroeconomic Indicators
  • Chapter 14 Generics in The United Kingdom
    • 14.1 Market Overview
    • 14.2 Market Value
    • 14.3 Market Segmentation I
    • 14.4 Market Segmentation II
    • 14.5 Five Forces Analysis
    • 14.6 Market Forecasts
    • 14.7 Macroeconomic Indicators
  • Chapter 15 Generics in The United States
    • 15.1 Market Overview
    • 15.2 Market Value
    • 15.3 Market Segmentation I
    • 15.4 Market Segmentation II
    • 15.5 Five forces analysis
    • 15.6 Market Forecasts
    • 15.7 Macroeconomic Indicators
  • Chapter 16 Company Profiles
    • 16.1 Leading Companies
  • Chapter 17 Appendix
  • List of Tables
    • Table 1: Global Generics Market Value: $ billion, 2002-2006
    • Table 2: Global Generics Market Segmentation I: % Share, by Value, 2006
    • Table 3: Global Generics Market Segmentation II: % Share, by Value, 2006
    • Table 4: Global Generics Market Value Forecast: $ billion, 2006-2011
    • Table 5: Asia-Pacific Generics Market Value: $ billion, 2002-2006
    • Table 6: Asia-Pacific Generics Market Segmentation I: % Share, by Value, 2006
    • Table 7: Asia-Pacific Generics Market Segmentation II: % Share, by Value, 2006
    • Table 8: Asia-Pacific Generics Market Value Forecast: $ billion, 2006-2011
    • Table 9: Europe Generics Market Value: $ billion, 2002-2006
    • Table 10: Europe Generics Market Segmentation I: % Share, by Value, 2006
    • Table 11: Europe Generics Market Segmentation II: % Share, by Value, 2006
    • Table 12: Europe Generics Market Value Forecast: $ billion, 2006-2011
    • Table 13: Europe Exchange Rate, 2002-2006
    • Table 14: Belgium Generics Market Value: $ million, 2002-2006
    • Table 15: Belgium Generics Market Segmentation I: % Share, by Value, 2006
    • Table 16: Belgium Generics Market Segmentation II: % Share, by Value, 2006
    • Table 17: Belgium Generics Market Value Forecast: $ million, 2006-2011
    • Table 18: Belgium Size of Population (million) , 2002-2006
    • Table 19: Belgium GDP (1995=100), 2002-2006
    • Table 20: Belgium Exchange Rate, 2002-2006
    • Table 21: Canada Generics Market Value: $ million, 2002-2006
    • Table 22: Canada Generics Market Segmentation I: % Share, by Value, 2006
    • Table 23: Canada Generics Market Segmentation II: % Share, by Value, 2006
    • Table 24: Canada Generics Market Value Forecast: $ million, 2006-2011
    • Table 25: Canada Size of Population (million) , 2002-2006
    • Table 26: Canada GDP (1995=100), 2002-2006
    • Table 27: Canada Inflation, 2002-2006
    • Table 28: Canada Exchange Rate, 2002-2006
    • Table 29: China Generics Market Value: $ billion, 2002-2006
    • Table 30: China Generics Market Segmentation I: % Share, by Value, 2006
    • Table 31: China Generics Market Segmentation II: % Share, by Value, 2006
    • Table 32: China Generics Market Value Forecast: $ billion, 2006-2011
    • Table 33: China Size of Population (million) , 2002-2006
    • Table 34: China GDP (1995=100), 2002-2006
    • Table 35: China Inflation, 2002-2006
    • Table 36: China Exchange Rate, 2002-2006
    • Table 37: France Generics Market Value: $ billion, 2002-2006
    • Table 38: France Generics Market Segmentation I: % Share, by Value, 2006
    • Table 39: France Generics Market Segmentation II: % Share, by Value, 2006
    • Table 40: France Generics Market Value Forecast: $ billion, 2006-2011
    • Table 41: France Size of Population (million) , 2002-2006
    • Table 42: France GDP (1995=100), 2002-2006
    • Table 43: France Inflation, 2002-2006
    • Table 44: France Exchange Rate, 2002-2006
    • Table 45: Germany Generics Market Value: $ billion, 2002-2006
    • Table 46: Germany Generics Market Segmentation I: % Share, by Value, 2006
    • Table 47: Germany Generics Market Segmentation II: % Share, by Value, 2006
    • Table 48: Germany Generics Market Value Forecast: $ billion, 2006-2011
    • Table 49: Germany Size of Population (million) , 2002-2006
    • Table 50: Germany GDP (1995=100), 2002-2006
    • Table 51: Germany Inflation, 2002-2006
    • Table 52: Germany Exchange Rate, 2002-2006
    • Table 53: Italy Generics Market Value: $ million, 2002-2006
    • Table 54: Italy Generics Market Segmentation I: % Share, by Value, 2006
    • Table 55: Italy Generics Market Segmentation II: % Share, by Value, 2006
    • Table 56: Italy Generics Market Value Forecast: $ million, 2006-2011
    • Table 57: Italy Size of Population (million) , 2002-2006
    • Table 58: Italy GDP (1995=100), 2002-2006
    • Table 59: Italy Inflation, 2002-2006
    • Table 60: Italy Exchange Rate, 2002-2006
    • Table 61: Japan Generics Market Value: $ billion, 2002-2006
    • Table 62: Japan Generics Market Segmentation I: % Share, by Value, 2006
    • Table 63: Japan Generics Market Segmentation II: % Share, by Value, 2006
    • Table 64: Japan Generics Market Value Forecast: $ billion, 2006-2011
    • Table 65: Japan Size of Population (million) , 2002-2006
    • Table 66: Japan GDP (1995=100), 2002-2006
    • Table 67: Japan Exchange Rate, 2002-2006
    • Table 68: Netherlands Generics Market Value: $ million, 2002-2006
    • Table 69: Netherlands Generics Market Segmentation I: % Share, by Value, 2006
    • Table 70: Netherlands Generics Market Segmentation II: % Share, by Value, 2006
    • Table 71: Netherlands Generics Market Value Forecast: $ million, 2006-2011
    • Table 72: Netherlands Size of Population (million) , 2002-2006
    • Table 73: Netherlands GDP (1995=100), 2002-2006
    • Table 74: Netherlands Exchange Rate, 2002-2006
    • Table 75: Spain Generics Market Value: $ million, 2002-2006
    • Table 76: Spain Generics Market Segmentation I: % Share, by Value, 2006
    • Table 77: Spain Generics Market Segmentation II: % Share, by Value, 2006
    • Table 78: Spain Generics Market Value Forecast: $ million, 2006-2011
    • Table 79: Spain Size of Population (million) , 2002-2006
    • Table 80: Spain GDP (1995=100), 2002-2006
    • Table 81: Spain Inflation, 2002-2006
    • Table 82: Spain Exchange Rate, 2002-2006
    • Table 83: United Kingdom Generics Market Value: $ billion, 2002-2006
    • Table 84: United Kingdom Generics Market Segmentation I: % Share, by Value, 2006
    • Table 85: United Kingdom Generics Market Segmentation II: % Share, by Value, 2006
    • Table 86: United Kingdom Generics Market Value Forecast: $ billion, 2006-2011
    • Table 87: United Kingdom Size of Population (million) , 2002-2006
    • Table 88: United Kingdom GDP (1995=100), 2002-2006
    • Table 89: United Kingdom Inflation, 2002-2006
    • Table 90: United Kingdom Exchange Rate, 2002-2006
    • Table 91: United States Generics Market Value: $ billion, 2002-2006
    • Table 92: United States Generics Market Segmentation I: % Share, by Value, 2006
    • Table 93: United States Generics Market Segmentation II: % Share, by Value, 2006
    • Table 94: United States Generics Market Value Forecast: $ billion, 2006-2011
    • Table 95: United States Size of Population (million) , 2002-2006
    • Table 96: United States GDP (1995=100), 2002-2006
    • Table 97: United States Inflation, 2002-2006
    • Table 98: Key Facts: Teva Pharmaceutical Industries
    • Table 99: Key Financials: Teva Pharmaceutical Industries
    • Table 100: Key Facts: Merck KGaA
    • Table 101: Key Financials: Merck KGaA
    • Table 102: Key Facts: Sandoz GmbH
  • List of Figures
    • Figure 1: Global Generics Market Value: $ billion, 2002-2006
    • Figure 2: Global Generics Market Segmentation I: % Share, by Value, 2006
    • Figure 3: Global Generics Market Segmentation II: % Share, by Value, 2006
    • Figure 4: Drivers of Buyer Power in the Global Generics Market, 2006
    • Figure 5: Drivers of Supplier Power in the Global Generics Market, 2006
    • Figure 6: Factors Influencing the Likelihood of New Entrants in the Global Generics Market, 2006
    • Figure 7: Factors Influencing the Threat of Substitutes in the Global Generics Market, 2006
    • Figure 8: Factors Influencing Degree of Rivalry in the Global Generics Market, 2006
    • Figure 9: Global Generics Market Value Forecast: $ billion, 2006-2011
    • Figure 10: Asia-Pacific Generics Market Value: $ billion, 2002-2006
    • Figure 11: Asia-Pacific Generics Market Segmentation I: % Share, by Value, 2006
    • Figure 12: Asia-Pacific Generics Market Segmentation II: % Share, by Value, 2006
    • Figure 13: Drivers of Buyer Power in the Generics Market in Asia-Pacific, 2006
    • Figure 14: Drivers of Supplier Power in the Generics Market in Asia-Pacific, 2006
    • Figure 15: Factors Influencing the Likelihood of New Entrants in the Generics Market in Asia-Pacific, 2006
    • Figure 16: Factors Influencing the Threat of Substitutes in the Generics Market in Asia-Pacific, 2006
    • Figure 17: Factors Influencing Degree of Rivalry in the Generics Market in Asia-Pacific, 2006
    • Figure 18: Asia-Pacific Generics Market Value Forecast: $ billion, 2006-2011
    • Figure 19: Europe Generics Market Value: $ billion, 2002-2006
    • Figure 20: Europe Generics Market Segmentation I: % Share, by Value, 2006
    • Figure 21: Europe Generics Market Segmentation II: % Share, by Value, 2006
    • Figure 22: Drivers of Buyer Power in the Generics Market in Europe, 2006
    • Figure 23: Drivers of Supplier Power in the Generics Market in Europe, 2006
    • Figure 24: Factors Influencing the Likelihood of New Entrants in the Generics Market in Europe, 2006
    • Figure 25: Factors Influencing the Threat of Substitutes in the Generics Market in Europe, 2006
    • Figure 26: Factors Influencing Degree of Rivalry in the Generics Market in Europe, 2006
    • Figure 27: Europe Generics Market Value Forecast: $ billion, 2006-2011
    • Figure 28: Belgium Generics Market Value: $ million, 2002-2006
    • Figure 29: Belgium Generics Market Segmentation I: % Share, by Value, 2006
    • Figure 30: Belgium Generics Market Segmentation II: % Share, by Value, 2006
    • Figure 31: Drivers of Buyer Power in the Generics Market in Belgium, 2006
    • Figure 32: Drivers of Supplier Power in the Generics Market in Belgium, 2006
    • Figure 33: Factors Influencing the Likelihood of New Entrants in the Generics Market in Belgium, 2006
    • Figure 34: Factors Influencing the Threat of Substitutes in the Generics Market in Belgium, 2006
    • Figure 35: Factors Influencing Degree of Rivalry in the Generics Market in Belgium, 2006
    • Figure 36: Belgium Generics Market Value Forecast: $ million, 2006-2011
    • Figure 37: Canada Generics Market Value: $ million, 2002-2006
    • Figure 38: Canada Generics Market Segmentation I: % Share, by Value, 2006
    • Figure 39: Canada Generics Market Segmentation II: % Share, by Value, 2006
    • Figure 40: Drivers of Buyer Power in the Generics Market in Canada, 2006
    • Figure 41: Drivers of Supplier Power in the Generics Market in Canada, 2006
    • Figure 42: Factors Influencing the Likelihood of New Entrants in the Generics Market in Canada, 2006
    • Figure 43: Factors Influencing the Threat of Substitutes in the Generics Market in Canada, 2006
    • Figure 44: Factors Influencing Degree of Rivalry in the Generics Market in Canada, 2006
    • Figure 45: Canada Generics Market Value Forecast: $ million, 2006-2011
    • Figure 46: China Generics Market Value: $ billion, 2002-2006
    • Figure 47: China Generics Market Segmentation I: % Share, by Value, 2006
    • Figure 48: China Generics Market Segmentation II: % Share, by Value, 2006
    • Figure 49: Drivers of Buyer Power in the Generics Market in China, 2006
    • Figure 50: Drivers of Supplier Power in the Generics Market in China, 2006
    • Figure 51: Factors Influencing the Likelihood of New Entrants in the Generics Market in China, 2006
    • Figure 52: Factors Influencing the Threat of Substitutes in the Generics Market in China, 2006
    • Figure 53: Factors Influencing Degree of Rivalry in the Generics Market in China, 2006
    • Figure 54: China Generics Market Value Forecast: $ billion, 2006-2011
    • Figure 55: France Generics Market Value: $ billion, 2002-2006
    • Figure 56: France Generics Market Segmentation I: % Share, by Value, 2006
    • Figure 57: France Generics Market Segmentation II: % Share, by Value, 2006
    • Figure 58: Drivers of Buyer Power in the Generics Market in France, 2006
    • Figure 59: Drivers of Supplier Power in the Generics Market in France, 2006
    • Figure 60: Factors Influencing the Likelihood of New Entrants in the Generics Market in France, 2006
    • Figure 61: Factors Influencing the Threat of Substitutes in the Generics Market in France, 2006
    • Figure 62: Factors Influencing Degree of Rivalry in the Generics Market in France, 2006
    • Figure 63: France Generics Market Value Forecast: $ billion, 2006-2011
    • Figure 64: Germany Generics Market Value: $ billion, 2002-2006
    • Figure 65: Germany Generics Market Segmentation I: % Share, by Value, 2006
    • Figure 66: Germany Generics Market Segmentation II: % Share, by Value, 2006
    • Figure 67: Drivers of Buyer Power in the Generics Market in Germany, 2006
    • Figure 68: Drivers of Supplier Power in the Generics Market in Germany, 2006
    • Figure 69: Factors Influencing the Likelihood of New Entrants in the Generics Market in Germany, 2006
    • Figure 70: Factors Influencing the Threat of Substitutes in the Generics Market in Germany, 2006
    • Figure 71: Factors Influencing Degree of Rivalry in the Generics Market in Germany, 2006
    • Figure 72: Germany Generics Market Value Forecast: $ billion, 2006-2011
    • Figure 73: Italy Generics Market Value: $ million, 2002-2006
    • Figure 74: Italy Generics Market Segmentation I: % Share, by Value, 2006
    • Figure 75: Italy Generics Market Segmentation II: % Share, by Value, 2006
    • Figure 76: Factors Influencing Degree of Rivalry in the Generics Market in Italy, 2006
    • Figure 77: Drivers of Supplier Power in the Generics Market in Italy, 2006
    • Figure 78: Factors Influencing the Likelihood of New Entrants in the Generics Market in Italy, 2006
    • Figure 79: Factors Influencing the Threat of Substitutes in the Generics Market in Italy, 2006
    • Figure 80: Factors Influencing Degree of Rivalry in the Generics Market in Italy, 2006
    • Figure 81: Italy Generics Market Value Forecast: $ million, 2006-2011
    • Figure 82: Japan Generics Market Value: $ billion, 2002-2006
    • Figure 83: Japan Generics Market Segmentation I: % Share, by Value, 2006
    • Figure 84: Japan Generics Market Segmentation II: % Share, by Value, 2006
    • Figure 85: Drivers of Buyer Power in the Generics Market in Japan, 2006
    • Figure 86: Drivers of Supplier Power in the Generics Market in Japan, 2006
    • Figure 87: Factors Influencing the Likelihood of New Entrants in the Generics Market in Japan, 2006
    • Figure 88: Factors Influencing the Threat of Substitutes in the Generics Market in Japan, 2006
    • Figure 89: Factors Influencing Degree of Rivalry in the Generics Market in Japan, 2006
    • Figure 90: Japan Generics Market Value Forecast: $ billion, 2006-2011
    • Figure 91: Netherlands Generics Market Value: $ million, 2002-2006
    • Figure 92: Netherlands Generics Market Segmentation I: % Share, by Value, 2006
    • Figure 93: Netherlands Generics Market Segmentation II: % Share, by Value, 2006
    • Figure 94: Drivers of Buyer Power in the Generics Market in the Netherlands, 2006
    • Figure 95: Drivers of Supplier Power in the Generics Market in the Netherlands, 2006
    • Figure 96: Drivers of Supplier Power in the Generics Market in the Netherlands, 2006
    • Figure 97: Factors Influencing the Threat of Substitutes in the Generics Market in the Netherlands, 2006
    • Figure 98: Factors Influencing Degree of Rivalry in the Generics Market in the Netherlands, 2006
    • Figure 99: Netherlands Generics Market Value Forecast: $ million, 2006-2011
    • Figure 100: Spain Generics Market Value: $ million, 2002-2006
    • Figure 101: Spain Generics Market Segmentation I: % Share, by Value, 2006
    • Figure 102: Spain Generics Market Segmentation II: % Share, by Value, 2006
    • Figure 103: Drivers of Buyer Power in the Generics Market in Spain, 2006
    • Figure 104: Drivers of Supplier Power in the Generics Market in Spain, 2006
    • Figure 105: Factors Influencing the Likelihood of New Entrants in the Generics Market in Spain, 2006
    • Figure 106: Factors Influencing the Threat of Substitutes in the Generics Market in Spain, 2006
    • Figure 107: Factors Influencing Degree of Rivalry in the Generics Market in Spain, 2006
    • Figure 108: Spain Generics Market Value Forecast: $ million, 2006-2011
    • Figure 109: United Kingdom Generics Market Value: $ billion, 2002-2006
    • Figure 110: United Kingdom Generics Market Segmentation I: % Share, by Value, 2006
    • Figure 111: United Kingdom Generics Market Segmentation II: % Share, by Value, 2006
    • Figure 112: Drivers of Buyer Power in the Generics Market in the United Kingdom, 2006
    • Figure 113: Drivers of Supplier Power in the Generics Market in the United Kingdom, 2006
    • Figure 114: Factors Influencing the Likelihood of New Entrants in the Generics Market in the United Kingdom, 2006
    • Figure 115: Factors Influencing the Threat of Substitutes in the Generics Market in the United Kingdom, 2006
    • Figure 116: Factors Influencing Degree of Rivalry in the Generics Market in the United Kingdom, 2006
    • Figure 117: United Kingdom Generics Market Value Forecast: $ billion, 2006-2011
    • Figure 118: United States Generics Market Value: $ billion, 2002-2006
    • Figure 119: United States Generics Market Segmentation I: % Share, by Value, 2006
    • Figure 120: United States Generics Market Segmentation II: % Share, by Value, 2006
    • Figure 121: Drivers of Buyer Power in the Generics Market in the United States, 2006
    • Figure 122: Drivers of Supplier Power in the Generics Market in the United States, 2006
    • Figure 123: Factors Influencing the Likelihood of New Entrants in the Generics Market in the United States, 2006
    • Figure 124: Factors Influencing the Threat of Substitutes in the Generics Market in the United States, 2006
    • Figure 125: Factors Influencing Degree of Rivalry in the Generics Market in the United States, 2006
    • Figure 126: United States Generics Market Value Forecast: $ billion, 2006-2011
    • Figure 127: Revenues &Profitability: Teva Pharmaceutical Industries
    • Figure 128: Revenues &Profitability : Merck KGaA